Roberto Barzi

vasopharm GmbH operates as a pharmaceutical company. It discovers and develops novel therapeutics for the treatment of cerebro and cardiovascular diseases and their consequences. The firm focuses on therapeutics influencing the bioavailability of nitric oxide. The company was founded by Harald Schmidt and Ulrich Walter in July 1998 and is headquartered in Wuerzburg, Germany.

Fort Rock Capital Ltd. provides investment services. The company is headquartered in London, the United Kingdom.

Part of Medinet Topco Ltd., Medinet Midco I Ltd. is a provider of specialised clinical teams that deliver additional elective services to the NHS. The private company is based in Sutton Coldfield, UK. Medinet Midco I offers urology and dermatology insourcing services, as well as fully managed specialised clinical teams. The British company was founded in 2016 and has been helping to reduce NHS waiting times for 15 years.

Part of Medinet Topco Ltd., Medinet Midco II Ltd. functions as an investment holding British company. The private company is based in Sutton Coldfield, UK and was founded in 2016.

Part of Medinet Topco Ltd., Medinet Clinical Services Ltd. is a leading provider of specialised clinical teams delivering additional elective services to the NHS. The private company is based in Sutton Coldfield, UK. The British company offers fully managed specialised clinical teams to help reduce NHS waiting times throughout the UK, including urology and general surgery insourcing. The company was founded in 2005 with the intention of easing the pressure on the NHS service, so that it can see and treat more patients.

Pregimmune Corp. is a private company based in Dover, DE. The company specializes in developing novel immunotherapies for pregnancy-related complications. The company's research focuses on understanding the immune system's role in pregnancy and developing therapies to prevent or treat complications such as preeclampsia, preterm birth, and fetal growth restriction.

Algenex SL develops and manufactures recombinant proteins. It specializes in the baculovirus vector-based innovative technologies to manufacture recombinant proteins used to produce vaccines, diagnostic reagents and therapeutic molecules. The company was founded by Jose Angel Martinez Escribano and Covadonga Alonso on January 19, 2005 and is headquartered in Pozuelo de Alarcon, Spain.